These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 16029582)
1. [Progress in the study of normal-sized ovary carcinoma syndrome]. Zeng DY; Shen J Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1149-51. PubMed ID: 16029582 [No Abstract] [Full Text] [Related]
2. The diagnostic challenge of ovarian carcinoma in normal-sized ovaries: a report of two cases. Yong SL; Dahian S; Ramlan AH; Kang M Horm Mol Biol Clin Investig; 2018 Aug; 35(1):. PubMed ID: 30098285 [TBL] [Abstract][Full Text] [Related]
3. CA-125 and early ovarian cancer: does this help the clinician or further muddy the water? McGuire WP J Clin Oncol; 2005 Sep; 23(25):5862-4. PubMed ID: 16087955 [No Abstract] [Full Text] [Related]
6. [Pathology of the ovary: Progress and alterations in diagnostics and therapy]. Schmidt D Pathologe; 2014 Jul; 35(4):312-3. PubMed ID: 24992973 [No Abstract] [Full Text] [Related]
7. An unusual presentation of Stage III ovarian carcinoma. Noor S; Khan R; Hollingworth A J Obstet Gynaecol; 2005 Aug; 25(6):619-20. PubMed ID: 16234164 [No Abstract] [Full Text] [Related]
8. Endometrioid cystadenofibroma of the ovary with pelvic lymph node involvement. Ceballos K; Daya D Int J Gynecol Pathol; 2006 Oct; 25(4):344-6. PubMed ID: 16990710 [No Abstract] [Full Text] [Related]
10. Prognostic role of CA-125 nadir in stage IV epithelial ovarian cancer. Prat A; Parera M; Del Campo JM J Clin Oncol; 2008 Apr; 26(10):1771-2; author reply 1772. PubMed ID: 18375912 [No Abstract] [Full Text] [Related]
11. Successful pregnancies following fertility-preserving treatment for ovarian carcinoma. Eitan R; Chi DS Nat Clin Pract Oncol; 2005 Dec; 2(12):647-51; quiz 652. PubMed ID: 16341120 [TBL] [Abstract][Full Text] [Related]
12. Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary. Ødegaard E; Davidson B; Elgaaen BV; Fagerhol MK; Engh V; Onsrud M; Staff AC Am J Obstet Gynecol; 2008 Apr; 198(4):418.e1-7. PubMed ID: 18241816 [TBL] [Abstract][Full Text] [Related]
13. The value of serum and tissular expression of CA 125 antigen, in evaluation of the response to second line chemotherapy for the relapsed ovarian carcinoma. Bădulescu F; Bădulescu A; Schenker M; Popescu CF; Stoica Z Rom J Morphol Embryol; 2005; 46(4):329-34. PubMed ID: 16688372 [TBL] [Abstract][Full Text] [Related]
14. ACR Appropriateness Criteria on staging and follow-up of ovarian cancer. Javitt MC J Am Coll Radiol; 2007 Sep; 4(9):586-9. PubMed ID: 17845961 [TBL] [Abstract][Full Text] [Related]
15. [The role of laparoscopy in the case of suspected advanced ovarian cancer (ascites, CA-125)]]. Kornovski J; Ismail E; Stoilov S; Ivanov S Akush Ginekol (Sofiia); 2016; 55 Suppl 1 Pt 1():29-37. PubMed ID: 27514168 [No Abstract] [Full Text] [Related]
17. [Clinical and pathomorphological problems in ovarian carcinoma]. Michalkiewicz W; Skommer G; Pisarski T Patol Pol; 1974; 25(2):265-73. PubMed ID: 4848287 [No Abstract] [Full Text] [Related]
18. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma. Seidman JD; Wang BG Gynecol Oncol; 2007 Jul; 106(1):201-6. PubMed ID: 17477958 [TBL] [Abstract][Full Text] [Related]
19. Uteruslike masses of the ovary associated with breast cancer and raised serum CA 125. Pai SA; Desai SB; Borges AM Am J Surg Pathol; 1998 Mar; 22(3):333-7. PubMed ID: 9500775 [TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer: real progress in early detection. Johns Hopkins Med Lett Health After 50; 2005 Jan; 16(11):3, 7. PubMed ID: 15693151 [No Abstract] [Full Text] [Related] [Next] [New Search]